“COVID-19 in Tralokinumab-Treated Patients With Moderate-to- Severe Atopic Dermatitis: Case Series from the ECZTEND Long- Term Extension Trial”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 6, Nov. 2021, p. s58, https://doi.org/10.25251/skin.5.supp.58.